Ramiah Oncology

09/12/2023

Privileged to be the first Penn-hosted visiting speaker from Johannesburg. Thanks Penn Medicine for being amazing hosts!

09/12/2023

Was an honour to be the Penn Invited speaker from Johannesburg!

12/12/2022

Great article which I'm proud to have been involved in which tracks the trends on breast cancer research over the past couple of decades, and shows it's evolution and the "eclectic nature of Radiation Oncology as a discipline, emphasizing the fact that technology and clinical management cannot evolve without each other in a virtuous process of constant growth and optimization"

08/12/2021

https://click.mail.medscape.com/?qs=90f872d0ff508f9ac30d28813e657cd7c833f6331ea23f3796aff9287595e3e964ce82b4ccc3ab5b5476b1dee310bc15aed7381ef95c0efd763f0b603d4b9e63

Men with localized prostate cancer who opt for surgery instead of surveillance are more than twice as likely to regret their decision.

15/09/2021

https://www.medscape.com/viewarticle/957917?spon=7&uac=374459AK&impID=3638120&sso=true&faf=1&src=WNL_mdpls_210914_mscpedit_honc

An oncologist looks at how owning a classic car helps her relate to and understand her posttreatment cancer patients.

11/09/2021

https://www.medscape.com/viewarticle/958060?spon=7&uac=374459AK&impID=3629912&sso=true&faf=1&src=WNL_mdpls_210910_mscpedit_honc

'You die with prostate cancer, not from it' is a common adage about the disease. But it's overwhelmingly not true when it comes to metastatic disease, new research indicates.

14/12/2020

" The findings of this cohort study confirm this model’s ability to predict posttreatment hearing outcomes in a unique population of patients. This model has the potential to inform pretreatment counseling and posttreatment hearing evaluations for this patient population."

This cohort study uses data from a cancer treatment facility and clinical audiometric database to assess the validity of a previously created dynamic nomogram and model for hearing loss to be used after treatment with chemoradiation for head and neck cancer.

14/12/2020

"Among women with early-stage triple-negative breast cancer, maintenance therapy with low-dose capecitabine significantly improved disease-free survival at 5 years."

This randomized trial compares the effects of low-dose high-frequency capecitabine maintenance therapy vs observation after standard adjuvant chemotherapy on 5-year disease-free survival among women with early-stage triple-negative breast cancer.

24/08/2020

https://www.medscape.org/viewarticle/933918_2
Immunotherapy is a new option for metastatic cutaneous squamous cell carcinoma

What is your role in treating patients with CSCC? Join Drs Nikhil Khushalani and Gino In as they discuss the role of the medical oncologist in CSCC treatment.

24/08/2020

https://www.medscape.org/viewarticle/934534_2

In episode 1, Dr Pearse Keane describes innovations in AI in ophthalmology and neurology and how they can improve patient care.

24/08/2020

https://www.medscape.com/viewarticle/935665?src=mkm_ret_200823_mscpmrk_oncology_lung_cancer_monthly&uac=374459AK&impID=2517687&faf=1

Bringing practices in line with standard of care requires understanding why they're diverging in the first place, says Dr Jack West.

20/08/2020

https://www.redjournal.org/article/S0360-3016(20)31043-9/fulltext?dgcid=raven_jbs_etoc_email